This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Luo, R. T.
Right arrow Articles by Thirman, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Luo, R. T.
Right arrow Articles by Thirman, M. J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2001, p. 5678-5687, Vol. 21, No. 16
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.16.5678-5687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

The Elongation Domain of ELL Is Dispensable but Its ELL-Associated Factor 1 Interaction Domain Is Essential for MLL-ELL-Induced Leukemogenesis

Roger T. Luo,1 Catherine Lavau,2,* Changchun Du,2 Federico Simone,1 Paul E. Polak,1 Shin Kawamata,2 and Michael J. Thirman1,*

Section of Hematology/Oncology, University of Chicago, Chicago, Illinois 60637,1 and Systemix, Palo Alto, California 943042

Received 29 December 2000/Returned for modification 28 February 2001/Accepted 8 May 2001

The MLL-ELL chimeric gene is the product of the (11;19)(q23p13.1) translocation associated with de novo and therapy-related acute myeloid leukemias (AML). ELL is an RNA polymerase II elongation factor that interacts with the recently identified EAF1 (ELL associated factor 1) protein. EAF1 contains a limited region of homology with the transcriptional activation domains of three other genes fused to MLL in leukemias, AF4, LAF4, and AF5q31. Using an in vitro transformation assay of retrovirally transduced myeloid progenitors, we conducted a structure-function analysis of MLL-ELL. Whereas the elongation domain of ELL was dispensable, the EAF1 interaction domain of ELL was critical to the immortalizing properties of MLL-ELL in vitro. To confirm these results in vivo, we transplanted mice with bone marrow transduced with MLL fused to the minimal EAF1 interaction domain of ELL. These mice all developed AML, with a longer latency than mice transplanted with the wild-type MLL-ELL fusion. Based on these results, we generated a heterologous MLL-EAF1 fusion gene and analyzed its transforming potential. Strikingly, we found that MLL-EAF1 immortalized myeloid progenitors in the same manner as that of MLL-ELL. Furthermore, transplantation of bone marrow transduced with MLL-EAF1 induced AML with a shorter latency than mice transplanted with the MLL-ELL fusion. Taken together, these results indicate that the leukemic activity of MLL-ELL requires the EAF1 interaction domain of ELL, suggesting that the recruitment by MLL of a transactivation domain similar to that in EAF1 or the AF4/LAF4/AF5q31 family may be a critical common feature of multiple 11q23 translocations. In addition, these studies support a critical role for MLL partner genes and their protein-protein interactions in 11q23 leukemogenesis.


* Corresponding author. Mailing address for Michael J. Thirman: 5841 South Maryland Ave., MC2115, Chicago, IL 60637. Phone: (773) 702-4133. Fax: (773) 702-8702. E-mail: mthirman{at}medicine.bsd.uchicago.edu. Present address for Catherine Lavau: CNRS UPR9051, IUH, Paris 75010, France. E-mail: catlav{at}chu-stlouis.fr.


Molecular and Cellular Biology, August 2001, p. 5678-5687, Vol. 21, No. 16
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.16.5678-5687.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zhou, J., Feng, X., Ban, B., Liu, J., Wang, Z., Xiao, W. (2009). Elongation Factor ELL (Eleven-Nineteen Lysine-rich Leukemia) Acts as a Transcription Factor for Direct Thrombospondin-1 Regulation. J. Biol. Chem. 284: 19142-19152 [Abstract] [Full Text]  
  • Slany, R. K. (2009). The molecular biology of mixed lineage leukemia. haematol 94: 984-993 [Abstract] [Full Text]  
  • Liu, J.-X., Hu, B., Wang, Y., Gui, J.-F., Xiao, W. (2009). Zebrafish eaf1 and eaf2/u19 Mediate Effective Convergence and Extension Movements through the Maintenance of wnt11 and wnt5 Expression. J. Biol. Chem. 284: 16679-16692 [Abstract] [Full Text]  
  • Ono, R., Ihara, M., Nakajima, H., Ozaki, K., Kataoka-Fujiwara, Y., Taki, T., Nagata, K.-i., Inagaki, M., Yoshida, N., Kitamura, T., Hayashi, Y., Kinoshita, M., Nosaka, T. (2005). Disruption of Sept6, a Fusion Partner Gene of MLL, Does Not Affect Ontogeny, Leukemogenesis Induced by MLL-SEPT6, or Phenotype Induced by the Loss of Sept4. Mol. Cell. Biol. 25: 10965-10978 [Abstract] [Full Text]  
  • Gerber, M. A., Shilatifard, A., Eissenberg, J. C. (2005). Mutational Analysis of an RNA Polymerase II Elongation Factor in Drosophila melanogaster. Mol. Cell. Biol. 25: 7803-7811 [Abstract] [Full Text]  
  • Kong, S. E., Banks, C. A. S., Shilatifard, A., Conaway, J. W., Conaway, R. C. (2005). ELL-associated factors 1 and 2 are positive regulators of RNA polymerase II elongation factor ELL. Proc. Natl. Acad. Sci. USA 102: 10094-10098 [Abstract] [Full Text]  
  • Pascual-Le Tallec, L., Simone, F., Viengchareun, S., Meduri, G., Thirman, M. J., Lombes, M. (2005). The Elongation Factor ELL (Eleven-Nineteen Lysine-Rich Leukemia) Is a Selective Coregulator for Steroid Receptor Functions. Mol. Endocrinol. 19: 1158-1169 [Abstract] [Full Text]  
  • Ayton, P. M., Chen, E. H., Cleary, M. L. (2004). Binding to Nonmethylated CpG DNA Is Essential for Target Recognition, Transactivation, and Myeloid Transformation by an MLL Oncoprotein. Mol. Cell. Biol. 24: 10470-10478 [Abstract] [Full Text]  
  • Sims, R. J. III, Belotserkovskaya, R., Reinberg, D. (2004). Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18: 2437-2468 [Abstract] [Full Text]  
  • Eguchi, M., Eguchi-Ishimae, M., Greaves, M. (2004). The small oligomerization domain of gephyrin converts MLL to an oncogene. Blood 103: 3876-3882 [Abstract] [Full Text]  
  • Yam, J. W. P., Jin, D.-Y., So, C. W., Chan, L. C. (2004). Identification and characterization of EBP, a novel EEN binding protein that inhibits Ras signaling and is recruited into the nucleus by the MLL-EEN fusion protein. Blood 103: 1445-1453 [Abstract] [Full Text]  
  • Zeisig, B. B., Milne, T., Garcia-Cuellar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., Hess, J. L., Slany, R. K. (2004). Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization. Mol. Cell. Biol. 24: 617-628 [Abstract] [Full Text]  
  • Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., Look, A. T. (2003). Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 102: 262-268 [Abstract] [Full Text]  
  • Wiederschain, D., Kawai, H., Gu, J., Shilatifard, A., Yuan, Z.-M. (2003). Molecular Basis of p53 Functional Inactivation by the Leukemic Protein MLL-ELL. Mol. Cell. Biol. 23: 4230-4246 [Abstract] [Full Text]  
  • Polak, P. E., Simone, F., Kaberlein, J. J., Luo, R. T., Thirman, M. J. (2003). ELL and EAF1 are Cajal Body Components That Are Disrupted in MLL-ELL Leukemia. Mol. Biol. Cell 14: 1517-1528 [Abstract] [Full Text]  
  • Simone, F., Luo, R. T., Polak, P. E., Kaberlein, J. J., Thirman, M. J. (2003). ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with alternative ELL binding properties. Blood 101: 2355-2362 [Abstract] [Full Text]  
  • So, C. W., Cleary, M. L. (2003). Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood 101: 633-639 [Abstract] [Full Text]  
  • So, C. W., Cleary, M. L. (2002). MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function. Mol. Cell. Biol. 22: 6542-6552 [Abstract] [Full Text]  
  • Dash, A. B., Williams, I. R., Kutok, J. L., Tomasson, M. H., Anastasiadou, E., Lindahl, K., Li, S., Van Etten, R. A., Borrow, J., Housman, D., Druker, B., Gilliland, D. G. (2002). A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc. Natl. Acad. Sci. USA 99: 7622-7627 [Abstract] [Full Text]